pharmeasy unlisted shares

    pharmeasy unlisted shares

    Share Price
    Historical price chart

    Enquiry

    Buy / Sell pharmeasy unlisted shares
    Current price: ₹8.00
    ₹8.00
    About pharmeasy unlisted shares
    Company overview and key information
    About PharmEasy Unlisted Shares

    Pharmeasy Share Price Full Details About the Company


    PharmEasy is India's leading digital healthcare platform. It provides information, consultations, diagnostics tests, medicines, healthcare products, and services from registered and trusted pharmacies, leading diagnostic laboratories, and trusted doctors across India, serving every habitable zip code of the country. The journey of PharmEasy was started in 2015, when founders Dharmil Sheth, an MBA from IMT Ghaziabad and Dr. Dhaval Shah, MBBS from Rajiv Gandhi Medical College and MBA from XLRI Jamshedpur, came up with the idea of an online pharmacy to make healthcare affordable and accessible to one and all.


    Overview of PharmEasy


    They are India’s largest digital healthcare platform (based on GMV of products and services sold for the year ended March 31, 2021), according to RedSeer Report. They operate an integrated, end-to-end business that aims to provide solutions for the healthcare needs of consumers across the following critical stages A. providing digital tools and information on illness and wellness.


    B. Offering Teleconsultation.


    C. Offering diagnostics and Radiology tests.


    D. delivering treatment protocols including products and devices. PharmEasy custom-built proprietary technology, unified data platforms, supply chain capabilities, and a deep understanding of the dynamic interplay between the various sub-segments of India’s healthcare market are the capabilities that differentiate us.


    These capabilities enable PharmEasy to provide each stakeholder in the healthcare value-chain, viz.: (a) channel (wholesalers, retailers, and chemists/institutions). (b) consultants (and hospitals), diagnostic and radiology labs. (c) consumers (d) companies (pharmaceutical, nutraceutical,medical devices.


    pharmeasy share price


    The businesses have a presence across the country, with last-mile 163 capabilities to deliver in over 18,587 pin codes (for June 2021) via PharmEasy marketplace, allowing the ability to provide access in an affordable manner to the common man. The platforms have scaled across urban, semi-urban, and rural India, with an ability to serve people across income groups and geographies.


    Journey of PharmEasy


    2015 - Started the journey in Mumbai and received angel funding.


    2016 - Received Series-A funding and expanded into 5 cities. The same year they have started a home-diagnostics service.


    2017 - Received Series-B funding and expanded into 700 cities. Launched online delivery of health care products.


    2018 - Received Series-C funding and expanded PAN India presence.


    2019 - Received Series-D funding and expanded more than 22000+ PIN codes.


    2020- It has got merged with Ascent Health and 5 other companies to form API Holdings, to form India’s biggest online healthcare company.


    2021 - It has purchased 66% stakes in Thyrocare and this is the first listed company to be acquired by any Unicorn in India. Currently, there is a team of 4000+ dedicated employees and have more than 10000+ retail stores working 24*7 to ensure medicines are delivered on time and at the best possible prices.


    Funding History

    March 2016~34 Crores
    March 2017~104 Crores
    April 2017~13 Crores
    February 2018~13 Crores
    September 2018~350 Crores
    September 2018~2800 Crores
    November 2019~1650 Crores
    April 2021~2400 Crores
    June 2021~150 Crores

    Product and Services


    If you check the website of PharmaEasy, you will find the following services;


    (i) Order Online Medicine


    How does it work?


    Step-1: The buyer needs to upload the prescription. Once PharmEasy receives it, they verify and send the same to the Medical stores near the pin code.


    Step-2: PhameEasy delivery agent then collects medicine from Pharmacy and delivers it to the user.


    (ii) Healthcare Products Similar to buying the medicine you can buy various healthcare products such as Nutritions, Personal care, Skin Care, Ayurvedic Products, Life-Style Ailments Products.


    (iii) Diagnostics Tests Under this service, you can book diagnostics tests under PharmEasy labs. PharmEasy labs is a diagnostic service offered by its partner lab Medlife Labs directly. Medlife is now being acquired by PharmEasy. As they have recently acquired Thyrocare, they are giving the option to book tests for these labs as well.


    PharmEasy Business Model


    The business model is very simple and straightforward. It connects buyers, suppliers, and distributors. Buyer has the option to choose services such as Medicine, Health-Care Products, book diagnostic tests, etc from the application and website. They get 1-2% commission on selling medicines, they get advertisement money for displaying products of various pharmaceuticals, Nutraceuticals, companies, etc., and also get income from diagnostics tests.




    PharmEasy Shareholding Pattern as on 31.03.2022 DRHP of PharmEasy

    PharmEasy Share Price Movement

    Source: UnlistedBuzz Note: Above Pharmeasy Share Price Graph is taken on 25th Jan 2021. For updated Pharmeasy unlisted share price, please consider downloading and installing our Android App. You can also check the live prices and historical prices of other unlisted shares currently trading in unlisted markets of India.

    Fundamentals
    Key financial metrics for PharmEasy Unlisted Shares
    Price Per Equity Share₹ 9
    Lot Size2500 Shares
    52 Week High₹ 13
    52 Week Low₹ 9
    DepositoryNSDL & CDSL
    PAN NumberAASCA1201E
    ISIN NumberINE0DJ201029
    CINU60100MH2019PLC323444
    RTALink Intime
    Market Cap (in cr.)₹ 5784
    P/E RatioN/A
    P/B Ratio2.23
    Debt to Equity1.58
    ROE (%)-97.89
    Book Value4.03
    Face Value1
    Total Shares6426735432

    Financials

    P&L Statement
    P&L Statement2021202220232024
    Revenue2335572966445664
    Cost of Material Consumed2267534256694737
    Gross Margins2.916.7614.6716.37
    Change in Inventory-114-22962143
    Employee Benefit Expenses27014591283699
    Other Expenses48215021051731
    EBITDA-570-2345-1421-646
    OPM-24.41-40.93-21.39-11.41
    Other Income25-1185-2866931
    Finance Cost43258666728
    D&A33159243216
    EBIT-603-2504-1664-862
    EBIT Margins-25.82-43.71-25.05-15.22
    PBT-621-3977-5196-2522
    PBT Margins-26.6-69.42-78.21-44.53
    Tax21221511
    PAT-642-3999-5211-2533
    NPM-27.49-69.8-78.43-44.72
    EPS-25.08-6.51-8.48-3.9
    Financial Ratios
    Financial Ratios2021202220232024
    Operating Profit Margin-24.41-40.93-21.39-11.41
    Net Profit Margin-27.49-69.8-78.43-44.72
    Earning Per Share (Diluted)-25.08-6.51-8.48-3.9

    Shareholding Patterns

    Progress for 2021

    Evermed Holdings Pte. Ltd14.65%
    MacRitchie Investments Pte. Ltd13.74%
    Prasid Uno Family Trust Through Its Trustee Surbhi Singh13.18%
    TPG Growth V SF Markets Pte. Ltd8.73%
    Lightrock Growth Fund I SA, SICAV-RAIF, For And On Behalf Of Lightrock Global Fund6.22%
    Others43.48%

    Promoters or Management

    NameDesignationExperienceLinkedIn
    Dr. Dhaval ShahCo-Founder, CBO9 YrsProfile
    Siddharth ShahCEO12 YrsProfile
    Abhinav Jain RankaCFO14 YrsProfile